Skip to main content

Table 4 Prognostic factors affecting LC and OS rates on univariate analysis

From: Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Factors Lesion (n°) LC (rates) pvalue Patients (n°) OS (rates) pvalue
1 years 2 years 3 years 1 years 2 years 3 years
Site of irradiated metastases  
    Lung 60 85% 75% 70% 0.095 40 87% 68% 58% 0.34
    Liver 52 95% 90% 81% 42 78% 61% 44%
Cumulative GTV  
    < 3 cm - - - - - 47 90% 70% 61% 0.02
    > 3 cm       35 73% 56% 26%
SBRT dose  
    ≥ 60 Gy 58 97% 92% 83% 0.043 46 80% 57% 38% 0.69
    < 60 Gy 52 85% 70% 70% 36 86% 54% -